Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs

E Eve Shaffer, An Pham, Robert L Woldman, Andrew Spiegelman, Scott A Strassels, George J Wan, Thomas Zimmerman, E Eve Shaffer, An Pham, Robert L Woldman, Andrew Spiegelman, Scott A Strassels, George J Wan, Thomas Zimmerman

Abstract

Introduction: The provision of safe, effective, cost-efficient perioperative inpatient acute pain management is an important concern among clinicians and administrators within healthcare institutions. Overreliance on opioid monotherapy in this setting continues to present health risks for patients and increase healthcare costs resulting from preventable adverse events. The goal of this study was to model length of stay (LOS), potential opioid-related complications, and costs for patients reducing opioid use and adding intravenous acetaminophen (IV APAP) for management of postoperative pain.

Methods: Data for this study were de-identified inpatient encounters from The Advisory Board Company across 297 hospitals from 2012-2014, containing 2,238,433 encounters (IV APAP used in 12.1%). Encounters for adults ≥18 years of age admitted for cardiovascular, colorectal, general, obstetrics and gynecology, orthopedics, or spine surgery were included. The effects of reducing opioids and adding IV APAP were estimated using hierarchical statistical models. Costs were estimated by multiplying modeled reductions in LOS or complication rates by observed average volumes for medium-sized facilities, and by average cost per day or per complication (LOS: US$2383/day; complications: derived from observed charges).

Results: Across all surgery types, LOS showed an average reduction of 18.5% (10.7-32.0%) for the modeled scenario of reducing opioids by one level (high to medium, medium to low, or low to none) and adding IV APAP, with an associated total LOS-related cost savings of $4.5 M. Modeled opioid-related complication rates showed similar improvements, averaging a reduction of 28.7% (5.4-44.0%) with associated cost savings of $0.2 M. In aggregate, costs decreased by an estimated $4.7 M for a medium-sized hospital. The study design demonstrates associations only and cannot establish causal relationships. The cost impact of LOS is modeled based on observed data.

Conclusions: This investigation indicates that reducing opioid use and including IV APAP for postoperative pain management has the potential to decrease LOS, opioid-related complication rates, and costs from a hospital perspective.

Funding: Mallinckrodt Pharmaceuticals.

Keywords: Cost; IV APAP; Intravenous acetaminophen; Length of stay; ORADE; Opioid; Opioid-related adverse drug events; Pain; Pharmacoeconomic; Postoperative.

References

    1. Gan TJ, Habib AS, Miller TE, et al. Incidence, patient satisfaction, and perception of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30(1):149–160. doi: 10.1185/03007995.2013.860019.
    1. Gramke HF, de Rijke JM, van Kleef M, et al. The prevalence of postoperative pain in a cross-sectional group of patients after day-case surgery in a university hospital. Clin J Pain. 2007;23(6):543–548. doi: 10.1097/AJP.0b013e318074c970.
    1. Joshi GP, Schug SA, Kehlet H. Procedure-specific pain management and outcome strategies. Best Pract Res Clin Anaesthesiol. 2014;28(2):191–201. doi: 10.1016/j.bpa.2014.03.005.
    1. Mwaka G, Thikra S. Mung’ayi V. Prevalence of postoperative pain in the first 48 hours following day surgery at a tertiary hospital in Nairobi. Afr Health Sci. 2013;13(3):768–776.
    1. Polomano RC, Dunwoody CJ, Krenzischek DA, et al. Perspective on pain management in the 21st century. J Perianesth Nurs. 2008;23:S4–S14. doi: 10.1016/j.jopan.2007.11.004.
    1. Coley KC, Williams BA, DaPos SV, et al. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002;14:349–353. doi: 10.1016/S0952-8180(02)00371-9.
    1. Buvanendran A. Multimodal analgesia for perioperative pain management. IARS Review Course Lectures. 2011. . Accessed March 24, 2016.
    1. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4):307–311. doi: 10.1001/jama.1997.03540280045032.
    1. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–306. doi: 10.1001/jama.1997.03540280039031.
    1. Phillips DM. JCAHO pain management standards are unveiled. JAMA. 2000;284(4):428. doi: 10.1001/jama.284.4.423b.
    1. ASA Task Force on Acute Pain Management Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248–273. doi: 10.1097/ALN.0b013e31823c1030.
    1. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306. doi: 10.1097/CCM.0b013e3182783b72.
    1. Gandhi K, Baratta JL, Heitz JW, et al. Acute pain management in the postanesthesia care unit. Anesthesiol Clin. 2012;30(3):e1–e15. doi: 10.1016/j.anclin.2012.09.001.
    1. Premier Healthcare Alliance [paid-access hospital research database: data from January 2011–March 2015]. Charlotte: Premier, Inc.; 2015.
    1. Zhao SZ, Chung F, Hanna DB, et al. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manag. 2004;28:35–46. doi: 10.1016/j.jpainsymman.2003.11.001.
    1. Kehlet H, Holte K. Review of postoperative ileus. Am J Surg. 2001;182(suppl 5A):3S–10S. doi: 10.1016/S0002-9610(01)00781-4.
    1. Cashman JN, Dolin SJ. Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data. Br J Anaesth. 2004;93:212–223. doi: 10.1093/bja/aeh180.
    1. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–S120.
    1. Kessler ER, Shah M, Gruschkus SK, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–391. doi: 10.1002/phar.1223.
    1. Oderda GM, Gan TJ, Johnson BH, et al. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013;27(1):62–70. doi: 10.3109/15360288.2012.751956.
    1. Suh DC, Kim MS, Chow W, et al. Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics. Clin J Pain. 2011;27(6):508–517. doi: 10.1097/AJP.0b013e31820d9b76.
    1. Pizzi LT, Toner R, Foley K, et al. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy. 2012;32:502–514. doi: 10.1002/j.1875-9114.2012.01101.x.
    1. Elvir-Lazo OL, White PF. The role of multimodal analgesia in pain management after ambulatory surgery. Curr Opin Anesthesiol. 2010;23:697–703. doi: 10.1097/ACO.0b013e32833fad0a.
    1. Maheshwari AV, Boutary M, Yun AG, et al. Multimodal analgesia without routine parenteral narcotics for total hip arthroplasty. Clin Orthop Relat Res. 2006;453:231–238. doi: 10.1097/01.blo.0000246545.72445.c4.
    1. Thiele RH, Rea KM, Turrentine FE, et al. Standardization of care: impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg. 2015;220(4):430–443. doi: 10.1016/j.jamcollsurg.2014.12.042.
    1. Subramanyam R, Varughese A, Kurth CD, Eckman MH. Cost-effectiveness of intravenous acetaminophen for pediatric tonsillectomy. Paediatr Anaesth. 2014;24(5):467–475. doi: 10.1111/pan.12359.
    1. El Chaar M, Stoltzfus J, Claros L, Wasylik T. IV acetaminophen results in lower hospital costs and emergency room visits following bariatric surgery: a double-blind, prospective, randomized trial in a single accredited bariatric center. J Gastrointest Surg. 2016;20(4):715–724. doi: 10.1007/s11605-016-3088-0.
    1. Jahr JS, Filocamo P, Singh S. Intravenous acetaminophen: a review of pharmacoeconomic science for perioperative use. Am J Ther. 2013;20(2):189–199. doi: 10.1097/MJT.0b013e31828900cb.
    1. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172:425–430. doi: 10.1001/archinternmed.2011.1827.
    1. Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine. 2007;32:2127–2132. doi: 10.1097/BRS.0b013e318145a731.
    1. Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176(9):1286–1293. doi: 10.1001/jamainternmed.2016.3298.
    1. Huang A, Azam A, Segal S, et al. Chronic postsurgical pain and persistent opioid use following surgery: the need for a transitional pain service. Pain Manag. 2016. [Epub ahead of print].
    1. Inacio MC, Hansen C, Pratt NL, Graves SE, Roughead EE. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open. 2016;6(4):e010664. doi: 10.1136/bmjopen-2015-010664.
    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49. doi: 10.15585/mmwr.rr6501e1.
    1. American Hospital Association (AHA). AHA data viewer—glossary. . Accessed August 1, 2016.
    1. Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74(8):1347–1354.
    1. Voepel-Lewis T, Wagner D, Burke C, et al. Early adjuvant use of nonopioids associated with reduced odds of serious postoperative opioid adverse events and need for rescue in children. Paediatr Anaesth. 2013;23(2):162–169. doi: 10.1111/pan.12026.
    1. Apfel C, Jahr JR, Ernst FR, et al. Effect of intravenous acetaminophen on total hip or knee surgery: a case-matched evaluation of a national hospital patient record database. Am J Health Syst Pharm. 2015;72:1961–1968. doi: 10.2146/ajhp140179.
    1. Centers for Medicare and Medicaid. HCAHPS: patients’ perspectives of care survey. . Accessed March 24, 2016.
    1. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102:822–831. doi: 10.1097/00000542-200504000-00019.
    1. Abdelmageed WM, Al Taher WM. Preoperative paracetamol infusion reduces sevoflurane consumption during thyroidectomy under general anesthesia with spectral entropy monitoring. Egyptian J Anaesth. 2014;30:115–122. doi: 10.1016/j.egja.2013.12.003.
    1. Arici S, Gurbet A, Türker G, et al. Preemptive analgesic effects of intravenous paracetamol in total abdominal hysterectomy. Agri. 2009;21(2):54–61.
    1. Atef A, Fawaz AA. Intravenous paracetamol is highly effective in pain treatment after tonsillectomy in adults. Eur Arch Otorhinolaryngol. 2008;265(3):351–355. doi: 10.1007/s00405-007-0451-5.
    1. Jokela R, Ahonen J, Seitsonen E, et al. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharm Ther. 2010;87:672–678. doi: 10.1038/clpt.2009.281.
    1. Smith AN, Hoefling VC. A retrospective analysis of intravenous acetaminophen use in spinal surgery patients. Pharmacy Pract. 2014;12(3):417–422.
    1. Hansen RN, Pham A, Balaban S, et al. Comparative analysis of inpatient costs for obstetrics and gynecology surgery patients treated with intravenous (IV) acetaminophen plus opioids or IV opioids alone for postoperative pain [abstract] J Women’s Health. 2016;25(4):A15.
    1. Hansen RN, Pham A, Strassels SA, Balaban S, Wan GJ. Comparative analysis of length of stay and inpatient costs for orthopedic surgery patients treated with IV acetaminophen and IV opioids vs. IV opioids alone for post-operative pain. Adv Ther. 2016;33(9):1635–1645. doi: 10.1007/s12325-016-0368-8.
    1. Shah MV, Maiese BA, Eaddy MT, et al. Hospitalization costs for patients undergoing orthopedic surgery treated with intravenous acetaminophen (IV-APAP) + IV opioids or IV opioids alone for postoperative pain. Annual Congress of Enhanced Recovery and Perioperative Medicine, April 20–22, 2016, Washington, DC, Poster presentation.
    1. Looke TD, Kluth CT. Effect of preoperative intravenous methocarbamol and intravenous acetaminophen on opioid use after primary total hip and knee replacement. Orthopedics. 2013;36(2 Suppl):25–32. doi: 10.3928/01477447-20130122-54.
    1. Smith AN, Hoefling VC. A retrospective analysis of intravenous acetaminophen use in spinal surgery patients. Pharm Pract (Granada). 2014;12(3):417. doi: 10.4321/S1886-36552014000300004.
    1. Mathiesen O, Dahl B, Thomsen BA, et al. A comprehensive multimodal pain treatment reduces opioid consumption after multilevel spine surgery. Eur Spine J. 2013;22(9):2089–2096. doi: 10.1007/s00586-013-2826-1.
    1. Walid MS, Hyer L, Ajjan M, Barth AC, Robinson JS Jr. Prevalence of opioid dependence in spine surgery patients and correlation with length of stay. J Opioid Manag. 2007;3(3):127–8, 130–2.
    1. Gelman A, Loken E. The garden of forking paths: Why multiple comparisons can be a problem, even when there is no “fishing expedition” or “p-hacking” and the research hypothesis was posited ahead of time. Department of Statistics, Columbia University, New York. .
    1. Simmons JP, Nelson LD, Simonsohn U. False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci. 2011;22(11):1359–1366. doi: 10.1177/0956797611417632.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren